Importance of bone assessment and prevention of osteoporotic fracture in patients with prostate cancer in the gonadotropic hormone analogues use
The antiandrogenic therapy (ADT) for prostate cancer represents an additional risk factor for the development of osteoporosis and fragility fractures. Still, bone health of patients on ADT is often not evaluated. After literature research we found that simple preventive measures can prevent bone loss in these patients, resulting in more cost-effective solutions to the public health system and family when compared to the treatment of fractures.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Digital revista |
| Language: | English |
| Published: |
Colégio Brasileiro de Cirurgiões
2015
|
| Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912015000200062 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|